paclitaxel has been researched along with Dermatitis, Contact in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Domb, AJ; Krasko, MY; Nyska, A; Shikanov, A; Vaisman, B | 1 |
Adamo, DO; Christian, MC; Davis, P; Kohn, EC; Link, CJ; Reed, E; Sarosy, GA | 1 |
2 other study(ies) available for paclitaxel and Dermatitis, Contact
Article | Year |
---|---|
Poly(sebacic acid-co-ricinoleic acid) biodegradable carrier for paclitaxel: in vitro release and in vivo toxicity.
Topics: Animals; Antineoplastic Agents, Phytogenic; Biodegradation, Environmental; Decanoic Acids; Delayed-Action Preparations; Dermatitis, Contact; Dicarboxylic Acids; Drug Carriers; Drug Implants; Female; Mice; Mice, Inbred BALB C; Paclitaxel; Polymers; Ricinoleic Acids | 2004 |
Cutaneous manifestations of Taxol therapy.
Topics: Antineoplastic Agents, Phytogenic; Dermatitis, Contact; Drug Therapy, Combination; Extravasation of Diagnostic and Therapeutic Materials; Female; Granulocyte Colony-Stimulating Factor; Humans; Middle Aged; Nail Diseases; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel | 1995 |